Inhibítory PCSK9 a postavenie evolokumabu v liečbe pacientov s hyperlipoproteinémiou = PCSK9 inhibitors and the role of evolocumab in the therapy for patients with hyperlipoproteinemia / Andrej Dukát ... [et al.]. Forum diabetologicum Roč. 7, č. 1 (2018), s. 71-75